Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
EACA proved useful in controlling severe bleeding after renal biopsy. In 6 patients who required transfusion for prolonged or severe bleeding, haemorrhage ceased and no further transfusions were necessary after EACA therapy. No serious side-effects were encountered.
D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D001706:Biopsy / Q000009:adverse effects*; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007668:Kidney / Q000601:surgery; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged
D000614:Aminocaproates; D015119:Aminocaproic Acid